◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Fuji Pharma Co., Ltd. (4554) Financial History

Name: Fuji Pharma Co., Ltd. (4554) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Fuji Pharma Co., Ltd. (4554) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 1,760 employees. Its market capitalization is roughly JPY 48 billion. In the fiscal year ended 2025-09-30, 4554 reported JPY 51.7B in revenue and JPY 3.0B in net income.

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products.

Interactive charts & full statements →

4554 Revenue & Earnings History — Annual Income Statement

Income statement	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Total Revenue	JPY 51.7B	JPY 46.1B	JPY 40.9B	JPY 35.4B	—
Gross Profit	JPY 20.8B	JPY 17.8B	JPY 16.5B	JPY 14.6B	—
Operating Income (EBIT)	JPY 5.0B	JPY 3.9B	JPY 3.9B	JPY 3.8B	—
Net Income	JPY 3.0B	JPY 6.1B	JPY 3.4B	JPY 2.7B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4554 Free Cash Flow History

Cash flow	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Dividends Paid	(JPY 1.0B)	(JPY 972M)	(JPY 899M)	(JPY 729M)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4554 Balance Sheet History

Balance sheet	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Total Assets	JPY 93.4B	JPY 90.0B	JPY 85.3B	JPY 75.5B	—
Total Liabilities	JPY 46.5B	JPY 44.4B	JPY 44.2B	JPY 39.7B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4554 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

4534 · Mochida Pharmaceutical Co., Ltd. — $114 billion
4559 · Zeria Pharmaceutical Co., Ltd. — $91 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — $64 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — $58 billion
2196 · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — $46 billion
GALD · GALDERMA GROUP N — $40 billion
4577 · Daito Pharmaceutical Co.,Ltd. — $37 billion
4595 · Mizuho Medy Co.,Ltd. — $33 billion

← 4553 All “0-9” companies 4558 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.